In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3

DSpace Repository

In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3

Author: Schmidt, Jana; Schmidt, Thorsten; Golla, Matthias; Lehmann, Lisa; Weber, Jonasz Jeremiasz; Huebener-Schmid, Jeannette; Riess, Olaf
Tübinger Autor(en):
Schmidt, Jana
Schmidt, Thorsten
Golla, Matthias
Lehmann, Lisa
Weber, Jonasz Jeremiasz
Hübener-Schmid, Jeannette
Rieß, Olaf
Published in: Journal of Neurochemistry (2016), Bd. 138, H. 1, S. 150-162
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/jnc.13606
ISSN: 1471-4159
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)